The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALBIREO PHARMA INC | Common | 01345P106 | 6,864,695 | 341,827 | SH | SOLE | 341,827 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | Common | 03753U106 | 9,414,319 | 212,329 | SH | SOLE | 212,329 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | Common | 03969K108 | 8,787,113 | 487,179 | SH | SOLE | 487,179 | 0 | 0 | ||
ASCENDIS PHARMA A/S | Sponsored ADR | 04351P101 | 7,953,761 | 68,404 | SH | SOLE | 68,404 | 0 | 0 | ||
ASTRIA THERAPEUTICS INC | Common | 04635X102 | 1,556,562 | 169,493 | SH | SOLE | 169,493 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | Common | 09058V103 | 3,751,030 | 340,163 | SH | SOLE | 340,163 | 0 | 0 | ||
BIOGEN INC | Common | 09062X103 | 2,169,987 | 7,660 | SH | SOLE | 7,660 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | Common | 23257D103 | 5,718,432 | 1,611,778 | SH | SOLE | 1,611,778 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | Common | 22663K107 | 11,336,501 | 623,819 | SH | SOLE | 623,819 | 0 | 0 | ||
CYTOKINETICS INC | Common | 23282W605 | 7,973,579 | 196,982 | SH | SOLE | 196,982 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | Common | 03152W109 | 4,893,334 | 566,179 | SH | SOLE | 566,179 | 0 | 0 | ||
HORIZON THERAPEUTICS PLC | SHS | G46188101 | 5,681,051 | 69,170 | SH | SOLE | 69,170 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | Common | 46565G104 | 7,027,867 | 342,071 | SH | SOLE | 342,071 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | Common | 483497103 | 6,697,459 | 719,937 | SH | SOLE | 719,937 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | Common | 16961L106 | 6,728,298 | 423,177 | SH | SOLE | 423,177 | 0 | 0 | ||
MORPHIC HLDG INC | Common | 61775R105 | 7,373,162 | 269,827 | SH | SOLE | 269,827 | 0 | 0 | ||
SAGE THERAPEUTICS INC | Common | 78667J108 | 5,367,609 | 156,085 | SH | SOLE | 156,085 | 0 | 0 | ||
THERAVANCE BIOPHARMA INC | Common | G8807B106 | 1,334,342 | 141,339 | SH | SOLE | 141,339 | 0 | 0 | ||
2SEVENTY BIO INC | Common | 901384107 | 9,885,521 | 684,996 | SH | SOLE | 684,996 | 0 | 0 |